Skip to main content
Top
Published in: Acta Diabetologica 6/2013

01-12-2013 | Original Article

Six cases with severe insulin resistance (SIR) associated with mutations of insulin receptor: Is a Bartter-like syndrome a feature of congenital SIR?

Authors: Valeria Grasso, Carlo Colombo, Valeria Favalli, Alfonso Galderisi, Ivana Rabbone, Sara Gombos, Enzo Bonora, Ornella Massa, Franco Meschi, Franco Cerutti, Dario Iafusco, Riccardo Bonfanti, Carla Monciotti, Fabrizio Barbetti

Published in: Acta Diabetologica | Issue 6/2013

Login to get access

Abstract

Biallelic insulin receptor (INSR) gene mutations cause congenital syndromes of severe insulin resistance (SIR) known as Donohue syndrome (DS) and Rabson–Mendenhall syndrome (RMS). At presentation, DS and RMS are difficult to differentiate since they share many clinical features; however, while patients with DS usually die within 1 year of birth, individuals classified as RMS can reach adult age. INSR mutations can be also found in pubertal females with hyperinsulinism, hyperandrogenism, and acanthosis nigricans (type A SIR). We studied the INSR gene in five subjects with congenital SIR and in a patient with type A SIR. Nine biallelic INSR gene mutations (eight novels, including an in-frame deletion of INSR signal peptide) were identified in patients with congenital SIR; a heterozygous, spontaneous INSR mutation was detected in the patient with type A SIR. Two probands, presenting severe hirsutism at birth, died at the age of 3 months and were classified as DS, while other 2, currently 2 and 3 years old, were diagnosed with RMS (patients 3 and 4). The fifth patient with congenital SIR died when 14 months old. Nephrocalcinosis, hyperaldosteronism, hyperreninemia, and hypokalemia, in the absence of hypertension, were discovered in patients 3 and 5 when 24 and 4 months old, respectively. Patient 3, now 3 years/3 months old, still shows hyperreninemic hyperaldosteronism requiring potassium supplementation. We conclude that renal abnormalities resembling antenatal Bartter’s syndrome type II, recently reported also by others, is a common observation in patients with congenital SIR.
Appendix
Available only for authorised users
Literature
1.
go back to reference Taylor SI, Cama A, Accili D, Barbetti F, Quon MJ et al (1992) Mutations in the insulin receptor gene. Endocr Rev 13:566–595PubMed Taylor SI, Cama A, Accili D, Barbetti F, Quon MJ et al (1992) Mutations in the insulin receptor gene. Endocr Rev 13:566–595PubMed
3.
go back to reference Musso C, Cochran E, Moran SA, Skarulis MC, Oral EA et al (2004) Clinical course of genetic diseases of the insulin receptor (type A and Rabson–Mendenhall syndromes): a 30-year prospective. Medicine (Baltimore) 83:209–222CrossRef Musso C, Cochran E, Moran SA, Skarulis MC, Oral EA et al (2004) Clinical course of genetic diseases of the insulin receptor (type A and Rabson–Mendenhall syndromes): a 30-year prospective. Medicine (Baltimore) 83:209–222CrossRef
4.
go back to reference Barbetti F, Gejman PV, Taylor SI, Raben N, Cama A et al (1992) Detection of mutations in insulin receptor gene by denaturing gradient gel electrophoresis. Diabetes 41:408–415PubMedCrossRef Barbetti F, Gejman PV, Taylor SI, Raben N, Cama A et al (1992) Detection of mutations in insulin receptor gene by denaturing gradient gel electrophoresis. Diabetes 41:408–415PubMedCrossRef
6.
go back to reference Wertheimer E, Barbetti F, Muggeo M, Roth J, Taylor SI (1994) Two mutations in a conserved structural motif in the insulin receptor inhibit normal folding and intracellular transport of the receptor. J Biol Chem 269:7587–7592PubMed Wertheimer E, Barbetti F, Muggeo M, Roth J, Taylor SI (1994) Two mutations in a conserved structural motif in the insulin receptor inhibit normal folding and intracellular transport of the receptor. J Biol Chem 269:7587–7592PubMed
7.
go back to reference Longo N, Wang Y, Smith SA, Langley SD, DiMeglio LA et al (2002) Genotype–phenotype correlation in inherited severe insulin resistance. Hum Mol Genet 11:1465–1475PubMedCrossRef Longo N, Wang Y, Smith SA, Langley SD, DiMeglio LA et al (2002) Genotype–phenotype correlation in inherited severe insulin resistance. Hum Mol Genet 11:1465–1475PubMedCrossRef
8.
go back to reference Moller DE, Cohen O, Yamaguchi Y, Assiz R, Grigorescu F et al (1994) Prevalence of mutations in the receptor gene in subjects with features of type A syndrome of insulin resistance. Diabetes 43:247–255PubMedCrossRef Moller DE, Cohen O, Yamaguchi Y, Assiz R, Grigorescu F et al (1994) Prevalence of mutations in the receptor gene in subjects with features of type A syndrome of insulin resistance. Diabetes 43:247–255PubMedCrossRef
9.
go back to reference Rau H, Kocova M, O'Rahilly S, Whitehead JP (2000) Naturally occurring aminoacid substitutions at Arg1174 in the human insulin receptor result in differential effects on receptor biosynthesis and hybrid formation, leading to discordant clinical phenotypes. Diabetes 49:1264–1268PubMedCrossRef Rau H, Kocova M, O'Rahilly S, Whitehead JP (2000) Naturally occurring aminoacid substitutions at Arg1174 in the human insulin receptor result in differential effects on receptor biosynthesis and hybrid formation, leading to discordant clinical phenotypes. Diabetes 49:1264–1268PubMedCrossRef
11.
go back to reference Liu M, Lara-Lemus R, Shu-ou S, Wright J, Haataja L, Barbetti F, Guo H, Larkin D, Arvan P (2012) Impaired cleavage of preproinsulin signal peptide linked to autosomal dominant diabetes. Diabetes 61:828–837. doi:10.2337/db11-0878 PubMedCrossRef Liu M, Lara-Lemus R, Shu-ou S, Wright J, Haataja L, Barbetti F, Guo H, Larkin D, Arvan P (2012) Impaired cleavage of preproinsulin signal peptide linked to autosomal dominant diabetes. Diabetes 61:828–837. doi:10.​2337/​db11-0878 PubMedCrossRef
12.
go back to reference Elders JM, Schedewie HK, Olefsky J, Givens B, Char F et al (1982) Endocrine-metabolic relationships in patients with leprechaunism. J Natl Med Assoc 74:1195–1210PubMed Elders JM, Schedewie HK, Olefsky J, Givens B, Char F et al (1982) Endocrine-metabolic relationships in patients with leprechaunism. J Natl Med Assoc 74:1195–1210PubMed
13.
go back to reference Unal S, Aycan Z, Halsall DJ, Kibar AE, Eker S et al (2009) Donohue syndrome in a neonate with homozygous deletion of exon 3 of the insulin receptor gene. J Pediatr Endocrinol Metab 22:669–674PubMedCrossRef Unal S, Aycan Z, Halsall DJ, Kibar AE, Eker S et al (2009) Donohue syndrome in a neonate with homozygous deletion of exon 3 of the insulin receptor gene. J Pediatr Endocrinol Metab 22:669–674PubMedCrossRef
14.
go back to reference Harris AM, Hall B, Kriss VM, Fowlkes JL, Kiessling SG (2007) Rabson–Mendenhall syndrome: medullary sponge kidney, a new component. Pediatr Nephrol 22:2141–2144PubMedCrossRef Harris AM, Hall B, Kriss VM, Fowlkes JL, Kiessling SG (2007) Rabson–Mendenhall syndrome: medullary sponge kidney, a new component. Pediatr Nephrol 22:2141–2144PubMedCrossRef
15.
go back to reference Abe Y, Sato T, Takagi M, Watanabe T, Nagayama Y et al (2012) A case of Rabson–Mendenhall syndrome with a novel mutation in the tyrosine kinase domain of the insulin receptor gene complicated by medullary sponge kidney. J Pediatr Endocrinol Metab 25:587–590PubMedCrossRef Abe Y, Sato T, Takagi M, Watanabe T, Nagayama Y et al (2012) A case of Rabson–Mendenhall syndrome with a novel mutation in the tyrosine kinase domain of the insulin receptor gene complicated by medullary sponge kidney. J Pediatr Endocrinol Metab 25:587–590PubMedCrossRef
18.
go back to reference Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A et al (1996) Genetic heterogeneity of Bartter’s syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 14:152–156PubMedCrossRef Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A et al (1996) Genetic heterogeneity of Bartter’s syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 14:152–156PubMedCrossRef
19.
go back to reference Hovnik T, Bratanic N, Trebusak Podkrajsek K, Kovac J, Paro D, et al (2012) Severe progressive obstructive cardiomyopathy and renal tubular dysfunction in Donohue syndrome with decreased insulin receptor autophosphorylation due to a novel INSR mutation. Eur J Pediatr published online 11 Dec 2012. doi:10.1007/s00431-012-1901-7 Hovnik T, Bratanic N, Trebusak Podkrajsek K, Kovac J, Paro D, et al (2012) Severe progressive obstructive cardiomyopathy and renal tubular dysfunction in Donohue syndrome with decreased insulin receptor autophosphorylation due to a novel INSR mutation. Eur J Pediatr published online 11 Dec 2012. doi:10.​1007/​s00431-012-1901-7
20.
go back to reference Vigneri R, Squatrito S, Sciacca L (2010) Insulin and its analogs: actions via insulin and IGF receptors. Acta Diabetol 47:271–278PubMedCrossRef Vigneri R, Squatrito S, Sciacca L (2010) Insulin and its analogs: actions via insulin and IGF receptors. Acta Diabetol 47:271–278PubMedCrossRef
23.
go back to reference Cochran E, Young JR, Sebring N, De Paoli A, Oral EA, Gorden P (2004) Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson–Mendenhall syndrome. J Clin Endocrinol Metab 89:1548–1554PubMedCrossRef Cochran E, Young JR, Sebring N, De Paoli A, Oral EA, Gorden P (2004) Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson–Mendenhall syndrome. J Clin Endocrinol Metab 89:1548–1554PubMedCrossRef
24.
go back to reference Hojlund K, Hansen T, Lajer M, Henriksen JE, Levin K et al (2004) A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene. Diabetes 53:1592–1598PubMedCrossRef Hojlund K, Hansen T, Lajer M, Henriksen JE, Levin K et al (2004) A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene. Diabetes 53:1592–1598PubMedCrossRef
Metadata
Title
Six cases with severe insulin resistance (SIR) associated with mutations of insulin receptor: Is a Bartter-like syndrome a feature of congenital SIR?
Authors
Valeria Grasso
Carlo Colombo
Valeria Favalli
Alfonso Galderisi
Ivana Rabbone
Sara Gombos
Enzo Bonora
Ornella Massa
Franco Meschi
Franco Cerutti
Dario Iafusco
Riccardo Bonfanti
Carla Monciotti
Fabrizio Barbetti
Publication date
01-12-2013
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 6/2013
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-013-0490-x

Other articles of this Issue 6/2013

Acta Diabetologica 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.